Detalles de la búsqueda
1.
Phase 1 study of ARQ 761, a ß-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis.
Br J Cancer
; 119(8): 928-936, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30318513
2.
Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer.
J Surg Oncol
; 116(1): 83-88, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28346693
3.
Rapid drug tolerance and dramatic sterilizing effect of moxifloxacin monotherapy in a novel hollow-fiber model of intracellular Mycobacterium kansasii disease.
Antimicrob Agents Chemother
; 59(4): 2273-9, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25645830
4.
Demographic and clinical features of inclusion body myositis in North America.
Muscle Nerve
; 52(4): 527-33, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25557419
5.
Quantification of myo-inositol, 1,5-anhydro- D-sorbitol, and D-chiro-inositol using high-performance liquid chromatography with electrochemical detection in very small volume clinical samples.
Biomed Chromatogr
; 29(11): 1629-36, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26010453
6.
Weight drives caspofungin pharmacokinetic variability in overweight and obese people: fractal power signatures beyond two-thirds or three-fourths.
Antimicrob Agents Chemother
; 57(5): 2259-64, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23459494
7.
Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners.
Antimicrob Agents Chemother
; 57(12): 5870-7, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24041886
8.
Ethambutol pharmacokinetic variability is linked to body mass in overweight, obese, and extremely obese people.
Antimicrob Agents Chemother
; 56(3): 1502-7, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22155817
9.
The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance.
Antimicrob Agents Chemother
; 56(9): 4806-15, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22751536
10.
Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability.
J Infect Dis
; 204(12): 1951-9, 2011 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22021624
11.
Pharmacokinetic mismatch does not lead to emergence of isoniazid- or rifampin-resistant Mycobacterium tuberculosis but to better antimicrobial effect: a new paradigm for antituberculosis drug scheduling.
Antimicrob Agents Chemother
; 55(11): 5085-9, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21896907
12.
Ribavirin improves early responses to peginterferon through improved interferon signaling.
Gastroenterology
; 139(1): 154-62.e4, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20303352
13.
Pharmacokinetics of oseltamivir in breast milk and maternal plasma.
Am J Obstet Gynecol
; 204(6): 524.e1-4, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21457910
14.
Pharmacokinetics of oseltamivir according to trimester of pregnancy.
Am J Obstet Gynecol
; 204(6 Suppl 1): S89-93, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21492824
15.
Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol.
J Infect Dis
; 201(8): 1225-31, 2010 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20210628
16.
Ethambutol optimal clinical dose and susceptibility breakpoint identification by use of a novel pharmacokinetic-pharmacodynamic model of disseminated intracellular Mycobacterium avium.
Antimicrob Agents Chemother
; 54(5): 1728-33, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20231389
17.
Moxifloxacin pharmacokinetics/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection.
Antimicrob Agents Chemother
; 54(6): 2534-9, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20385862
18.
Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non-Small Cell Lung Cancer.
Clin Cancer Res
; 26(22): 6017-6027, 2020 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32847935
19.
Pharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs.
Antimicrob Agents Chemother
; 53(8): 3197-204, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19451303
20.
Effects of atazanavir/ritonavir or fosamprenavir/ritonavir on the pharmacokinetics of rosuvastatin.
J Cardiovasc Pharmacol
; 51(6): 605-10, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18520949